Clinical Research

At any given time, DVU physicians are engaged in a variety of research programs to evaluate new drugs, therapies and treatments with the potential to find new cures for urologic disorders and disease. We are proud of the leadership role our doctors take in helping to prove the safety and efficacy of new treatments, and of the opportunity it gives us to make those options available to our patients. Those potential advantages, however, are always considered in the context of the overall health and well-being of our patients. If you think you might be eligible for and interested in participating in a clinical research program, your DVU urologist will discuss the potential benefits and risks with you so that you and your family can make an informed decision.

Clinical Research Experience
Delaware Valley Urology, LLC, has extensive experience in conducting Phase 1B-IV trials in the following urological therapeutic areas:

  • Bladder cancer
  • BPH (Benign Prostatic Hyperplasia)
  • Erectile dysfunction/impotence
  • High Grade PIN
  • Hypogonadism
  • Neurogenic bladder
  • Overactive bladder
  • Premature ejaculation
  • Prostate cancer
  • Prostate cancer prevention
  • Prostatitis
  • Urinary incontinence
  • Urinary tract infection treatment

Our research center has worked with a variety of sponsor companies and CRO’s including:

  • Abbott
  • Advanced Biologics
  • Allergan
  • Amgen
  • Astra-Zeneca
  • Barr-Laboratories, Inc.
  • Bayer
  • Bionche
  • Boehringer Ingelheim Pharmaceuticals
  • Glaxo Smith Kline
  • GTx Inc.
  • Kendle International, Inc.
  • MDS Pharma Services
  • Merck
  • Novartis
  • Oakwood
  • Ortho-McNeil
  • Pallisades Pharmaceuticals
  • PCRS
  • Pfizer
  • Pharmacia
  • PPD
  • Quintiles
  • Schering-Phough
  • Spectrum
  • TAP Pharmaceutical Products, Inc.
  • Upjohn Company
  • Zentaris

Staff Expertise
DVU employs four full-time study coordinators as listed below:

Renee Haney, MA, CCRC, Director of Clinical Research
Barbara Schaffhauser, LPN, CRC
Michelle Savino, LPN, CRC
E. Jael Johnson, CMA, CRC

Current Trials
DVU centers are actively recruiting patients for the following trials:

•Benign Prostatic Hyperplasia (BPH)
A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate

•Interstitial Cystitis

•Bladder cancer
Have you been diagnosed with Prostate Cancer, Chronic Prostatitis, or Benign Prostatic Hyperplasia (BPH)?

•Overactive bladder

•Prostate cancer

•Prostate cancer with bone mets

To make an appointment with a DVU physician with expertise in Clinical Research please send an email to: ClinicalResearch@dvullc.com